Long-term Outcomes and Toxicity in Patients with Metastatic Non Small Cell Lung Cancer Treated with Immunotherapy Containing Regimens

被引：0
|
作者：
Maddula, M. [1 ,2 ]
Brown, L. J. [1 ,2 ,3 ,4 ]
Gao, B. [1 ,2 ,3 ]
da Silva, I. Pires [1 ,2 ,3 ,5 ]
Nagrial, A. [1 ,2 ,3 ]
机构：
[1] Westmead Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia
[2] Blacktown Hosp, Med Oncol, Sydney, NSW, Australia
[3] Univ Sydney, Camperdown, NSW, Australia
[4] Westmead Inst Med Res, Westmead, NSW, Australia
[5] Melanoma Inst Australia, Sydney, NSW, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Metastatic Non Small Cell Lung Cancer; Immunotherapy; Long-term outcomes;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-07
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [31] Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer
    Jochen Fleckenstein
    Alev Petroff
    Hans-Joachim Schäfers
    Thomas Wehler
    Jakob Schöpe
    Christian Rübe
    BMC Cancer, 16
  • [32] Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer
    Fleckenstein, Jochen
    Petroff, Alev
    Schaefers, Hans-Joachim
    Wehler, Thomas
    Schoepe, Jakob
    Ruebe, Christian
    BMC CANCER, 2016, 16
  • [33] Are there Ethnic Disparities in the Clinical Outcomes of Non-Small Cell Lung Cancer Hispanic Patients Treated with Immunotherapy?
    Raez, L.
    Saravia, D.
    Munoz-Antonia, T.
    Ruiz, R.
    Cress, D.
    Chiappori, A.
    Hunis, B.
    Sumarriva, D.
    Power, H.
    Mas Lopez, L. A.
    Lopes, G.
    Izquierdo, P.
    Antonia, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S826 - S826
  • [34] Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimens
    Yan, Lily Z.
    Dressler, Emily V.
    Adams, Val R.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2018, 24 (03) : 209 - 217
  • [35] Analysis of long-term outcomes and prognostic factors in patients with non-small cell lung cancer brain metastases treated by gamma knife radiosurgery
    Gerosa, M
    Nicolato, A
    Foroni, R
    Tomazzoli, L
    Bricolo, A
    JOURNAL OF NEUROSURGERY, 2005, 102 : 75 - 80
  • [36] Real-world outcomes of immunotherapy regimens in first line non small cell lung cancer in lebanese patients.
    Nasr, Lewis
    Diab, Saada
    Ghoche, Ahmad
    Yehia, Intissar
    Nasr, Fadi Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18741 - E18741
  • [37] Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors
    Nadal, Ernest
    Massuti, Bartomeu
    Domine, Manuel
    Garcia-Campelo, Rosario
    Cobo, Manuel
    Felip, Enriqueta
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (03) : 341 - 352
  • [38] Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors
    Ernest Nadal
    Bartomeu Massuti
    Manuel Dómine
    Rosario García-Campelo
    Manuel Cobo
    Enriqueta Felip
    Cancer Immunology, Immunotherapy, 2019, 68 : 341 - 352
  • [39] Clinical features of patients with advanced non-squamous non-small cell lung cancer treated with long-term pemetrexed
    Hirai, Kenichiro
    Yokouchi, Hiroshi
    Azuma, Keisuke
    Minemura, Hiroyuki
    Sekine, Satoko
    Kanazawa, Kenya
    Tanino, Yoshinori
    Munakata, Mitsuru
    ANNALS OF ONCOLOGY, 2015, 26 : 123 - 123
  • [40] Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer (MNSCLC) with Brain Metastases Treated with Pembrolizumab
    Sun, L.
    Davis, C.
    Marmarelis, M.
    Singh, A.
    Berman, A.
    Feigenberg, S.
    Levin, W.
    Bauml, J.
    Cohen, R.
    Langer, C.
    Aggarwal, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1131 - S1131
12345